Compare BRBS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRBS | EMBC |
|---|---|---|
| Founded | 1893 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.2M | 328.1M |
| IPO Year | 2015 | 2021 |
| Metric | BRBS | EMBC |
|---|---|---|
| Price | $3.98 | $6.53 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 997.1K | 817.2K |
| Earning Date | 10-26-2026 | 11-24-2026 |
| Dividend Yield | ★ 21.20% | 0.59% |
| EPS Growth | ★ 135.48 | 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $111,284,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.59 |
| P/E Ratio | ★ N/A | $6.61 |
| Revenue Growth | ★ 123.99 | N/A |
| 52 Week Low | $3.23 | $2.77 |
| 52 Week High | $4.79 | $14.91 |
| Indicator | BRBS | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 66.20 |
| Support Level | $3.79 | $3.01 |
| Resistance Level | $4.07 | $9.38 |
| Average True Range (ATR) | 0.08 | 0.28 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 51.41 | 84.55 |
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.